Genetic Technologies Ltd (GENE)

US37185R4065 - ADR

0.765  -0.02 (-1.92%)

After market: 0.75 -0.02 (-1.96%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
6.795M
5,536.52%		8.686M
27.83%		7.665M
-11.76%
EBITDA
YoY % growth
N/AN/AN/A
EBIT
YoY % growth
-7.57M
1.51%		-10.195M
-34.68%		-10.615M
-4.12%
Operating Margin
-111.41%-117.37%-138.49%
EPS
YoY % growth
N/AN/AN/A

All data in AUD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in AUD

Recent Earnings VS Estimates Surprises (AUD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (AUD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth		 3.706M
-18.23%		%
Q2 2024
Q2Q % growth		 3.959M
-4.70%		%
Q4 2023
Q2Q % growth		 4.532M
-4.46%		%
Q2 2023
Q2Q % growth		 4.154M
102.53%		%
Q4 2022
Q2Q % growth		 4.744M
4,456.09%		%
Q2 2022
Q2Q % growth		 2.051M
12,375.79%		%
Q4 2021
Q2Q % growth		 104.12K
1,021.98%		%
Q2 2021
Q2Q % growth		 16.44K
2,686.44%		%
Q4 2020
Q2Q % growth		 9.28K
31.82%		%
Q2 2020
Q2Q % growth		 590
-96.79%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A